What does OncoCyte Corp. do?

Jun 22 2025 06:50 PM IST
share
Share Via
OncoCyte Corporation is a development-stage biotechnology company specializing in molecular cancer diagnostics, with a market cap of $91.52 million and recent net sales of $2 million, but a net loss of $7 million. The company has no dividend yield and significant negative return on equity.
Overview:
OncoCyte Corporation is a development-stage biotechnology company focused on molecular cancer diagnostics within the Pharmaceuticals & Biotechnology industry. Financial Snapshot: Most recent Net Sales: 2 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -7 Million (Quarterly Results - Mar 2025) Market cap: USD 91.52 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -2.90 Return on Equity: -225.22% Price to Book: 8.96 Contact Details: Address: 15 CUSHING, IRVINE CA: 92618 Tel: ['1 949 4097600', '1 646 5976979'] Fax: 1 510 5213389 Website: http://www.oncocyte.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
OncoCyte Corp. Hits New 52-Week High of $6.76, Up 146.47%
Oct 27 2025 04:58 PM IST
share
Share Via
Is OncoCyte Corp. technically bullish or bearish?
Sep 20 2025 07:53 PM IST
share
Share Via
Is OncoCyte Corp. overvalued or undervalued?
Sep 20 2025 06:27 PM IST
share
Share Via
Is OncoCyte Corp. overvalued or undervalued?
Jun 25 2025 09:06 AM IST
share
Share Via
Is OncoCyte Corp. technically bullish or bearish?
Jun 25 2025 08:53 AM IST
share
Share Via
Who are in the management team of OncoCyte Corp.?
Jun 22 2025 10:36 PM IST
share
Share Via